Baker Bros. Advisors’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,939
| Closed | -$115K | – | 100 |
|
|
2018
Q2 | $115K | Sell |
2,939
-14,053
| -83% | -$550K | ﹤0.01% | 117 |
|
|
2018
Q1 | $618K | Sell |
16,992
-17,853
| -51% | -$649K | 0.01% | 108 |
|
|
2017
Q4 | $3.02M | Buy |
34,845
+10,000
| +40% | +$866K | 0.03% | 89 |
|
|
2017
Q3 | $3.05M | Hold |
24,845
| – | – | 0.02% | 87 |
|
|
2017
Q2 | $2.29M | Hold |
24,845
| – | – | 0.02% | 82 |
|
|
2017
Q1 | $5.5M | Hold |
24,845
| – | – | 0.05% | 63 |
|
|
2016
Q4 | $3.5M | Hold |
24,845
| – | – | 0.03% | 73 |
|
|
2016
Q3 | $4.23M | Hold |
24,845
| – | – | 0.04% | 72 |
|
|
2016
Q2 | $6.7M | Buy |
24,845
+5,051
| +26% | +$1.36M | 0.07% | 65 |
|
|
2016
Q1 | $5.54M | Hold |
19,794
| – | – | 0.06% | 71 |
|
|
2015
Q4 | $5.74M | Hold |
19,794
| – | – | 0.05% | 74 |
|
|
2015
Q3 | $9.5M | Buy |
+19,794
| New | +$9.5M | 0.09% | 63 |
|
|
2015
Q1 | – | Sell |
-3,369
| Closed | -$3.24M | – | 131 |
|
|
2014
Q4 | $3.24M | Hold |
3,369
| – | – | 0.03% | 85 |
|
|
2014
Q3 | $4.11M | Hold |
3,369
| – | – | 0.05% | 68 |
|
|
2014
Q2 | $3.71M | Hold |
3,369
| – | – | 0.05% | 78 |
|
|
2014
Q1 | $4.37M | Buy |
+3,369
| New | +$4.37M | 0.06% | 78 |
|